Global /India /Healthcare /Drug Manufacturers - General /INDGN

Indegene Ltd.

INDGN

• NSE: INDGN • Delayed

499.75INR 0.9%

5.24 USD

As of 7 June 2026, Indegene Ltd. has a market cap of $1.24B USD, ranking #9496 globally and #515 in India. It ranks #816 in the Healthcare sector, and #309 in the Drug Manufacturers - General industry.

Global Rank

9496

Country Rank

515

Sector Rank

816

Industry Rank

309

Key Stats

Market Cap

$1.24BUSD

118.91B INR

Enterprise Value

$1.13BUSD

107.45B INR

Revenue (TTM)

$340.75MUSD

32.63B INR

EBITDA (TTM)

$57.88MUSD

5.52B INR

Net Income (TTM)

$45.85MUSD

4.39B INR

EBITDA Margin

17%

Profit Margin

13%

PE Ratio

27.2

Forward PE

23.8

PS Ratio

3.6

PB Ratio

4.1

EV/EBITDA

18.5

Company Profile

Country (HQ)

India

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Manish Gupta open_in_new

Employees

4,158

Founded

1998

Website

indegene.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
0.9%	1.3%	10%	6.4%	-8.5%	-4.1%	-11%	-20%	-20%

News

Markets

Exchange	Ticker	Price	Quotes
National Stock Exchange of India (NSE) MIC: XNSE PRIMARY	INDGN Indegene Ltd ISIN: INE065X01017 Shares Out.: Shares Outstanding: 240.954M¹ Shares Float: 83.602M² TV: TradingView: NSE: INDGN SA: Stock Analysis: NSE: INDGN YF: Yahoo Finance: INDGN.NS GF: Google Finance: NSE: INDGN BA: Barron's: INDGN MS: Morningstar: XNSE: INDGN	499.75 INR	TV: TradingView: NSE: INDGN SA: Stock Analysis: NSE: INDGN YF: Yahoo Finance: INDGN.NS GF: Google Finance: NSE: INDGN BA: Barron's: INDGN MS: Morningstar: XNSE: INDGN
Bombay Stock Exchange (BSE / BOM) MIC: XBOM	544172 (INDGN) Indegene Ltd ISIN: INE065X01017 TV: TradingView: BSE: INDGN SA: Stock Analysis: BOM: 544172 YF: Yahoo Finance: 544172.BO GF: Google Finance: BOM: 544172 BA: Barron's: 544172 MS: Morningstar: XBOM: 544172	495.40 INR	TV: TradingView: BSE: INDGN SA: Stock Analysis: BOM: 544172 YF: Yahoo Finance: 544172.BO GF: Google Finance: BOM: 544172 BA: Barron's: 544172 MS: Morningstar: XBOM: 544172

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Indegene Ltd.

Indegene Limited operates as a digital-first life sciences commercialization company in India, the United States, Europe, and internationally. It operates through three segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation & Others. The company develops biotech and medical device for biopharmaceutical, emerging biotech, and medical device companies. It also offers enterprise commercial, medical, and clinical solutions; and omnichannel activation solutions. In addition, the company operates NEXT technology platforms. Further, it provides analytics, technology, commercial, medical, regulatory, and safety services to life science and healthcare organizations. Indegene Limited was incorporated in 1998 and is based in Bengaluru, India.

Similar Companies

Industry: Drug Manufacturers - General (India)

Name	Market Cap (USD) diff.	PE	Country
Sun Pharmaceutical Industries Ltd. NSE: SUNPHARMA	$44.57B 4.27T INR 3K%	39.1	India
Divi's Laboratories Ltd. NSE: DIVISLAB	$18.12B 1.73T INR 1K%	70.0	India
Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM	$14.95B 1.43T INR 1K%	63.0	India
Dr. Reddy's Laboratories Ltd. NSE: DRREDDY	$11.57B 1.11T INR 831%	19.6	India
Mankind Pharma Ltd. NSE: MANKIND	$9.73B 931.67B INR 683%	52.2	India
Zydus Lifesciences Ltd. NSE: ZYDUSLIFE	$9.57B 916.53B INR 671%	18.6	India

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 61K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 44K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 29K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 26K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 23K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 22K%	20.5	Switzerland

chevron_leftBack